BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35680491)

  • 1. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
    Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
    Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
    Trilianos P; Selaru F; Li Z; Gurakar A
    Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
    Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
    Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
    von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
    Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
    Quinn KP; Tabibian JH; Lindor KD
    Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
    Ahmad J
    Hepatol Int; 2018 Nov; 12(6):510-519. PubMed ID: 30430358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fevery J; Verslype C; Lai G; Aerts R; Van Steenbergen W
    Dig Dis Sci; 2007 Nov; 52(11):3123-35. PubMed ID: 17431781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
    Saca D; Flamm SL
    Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
    Fung BM; Tabibian JH
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of cholangiocarcinoma.
    Bergquist A; von Seth E
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
    Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
    Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.